
ENT & Bronchoscopy Devices Market Size, Share, & COVID-19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: ENT Endoscopes, ENT Powered Instruments, and 9 more
- Year: 2023
- Scope: 10 Years
- Region: United States
- Pages: 399
- Published Date: 12/15/2022
- Type: MedSuite
Overall, the U.S. ENT endoscopic and bronchoscopic device market was valued at around $1.2 billion in 2022. This is expected to increase over the forecast period at a CAGR of 3.8% to reach just over $1.6 billion.
The full report suite on the U.S. market for ENT endoscopic and bronchoscopic devices includes ENT endoscopes, ENT powered instruments, ENT hand instruments, ENT surgical energy devices, balloon dilation devices, drug-eluting stents, bronchoscopes, bronchoscopic hand instruments, tracheobronchial stents, bronchoscopic biopsy devices and foreign body removal devices.
MARKET DATA INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- COVID-19 Impact Analysis
- Market Drivers & Limiters
- Market Forecasts Until 2027, and Historical Data to 2017
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
PROCEDURE NUMBERS
In 2022, the number of ENT procedures performed in the U.S. showed a moderate increase over the previous year. Sinus procedures include endoscopic sinus procedures, septoplasty, and turbinate reductions. Ear procedures include tympanoplasty, mastoidectomy, myringotomy and throat procedures, including tonsillectomies and adenoidectomies.
U.S. ENT DEVICE MARKET INSIGHTS
Single-use devices, especially single-use endoscopes and bronchoscopes, have become increasingly popular in the ENT endoscopic and bronchoscopic device market. The benefits of single-use devices include a decreased risk of infection and no reprocessing after use. Recently, single-use devices have gained significant traction in the bronchoscope market.
U.S. ENT DEVICE MARKET SHARE INSIGHTS
The U.S. ENT device market was controlled by Acclarent and Olympus.In 2022, the leading competitor in the overall ENT endoscopic and bronchoscopic device market was Acclarent. The company participated solely in the balloon dilation device segment of the ENT endoscopic device market, where it held a majority share.
MARKET SEGMENTATION SUMMARY
- Procedure Volumes for ENT and Bronchoscopy Procedures – MedPro – Using a number of databases, internal and external, we’re able to provide you with the total volume of ENT procedures being performed for each of the markets mentioned in this suite of reports.
- ENT Endoscope Market – MedCore – Segmented into 2 main markets: rigid ENT endoscopes and flexible ENT endoscopes.
- ENT Powered Instrument Market – MedCore – Segmented into 2 main markets: ENT powered instrument capital equipment and ENT powered instrument disposables.
- ENT Hand Instrument Market – MedCore – This market covers several types ENT of hand instruments including sinus hand instruments, laryngeal hand instruments, and otology hand instruments.
- ENT Surgical Energy Device Market – MedCore – Segmented into 2 main markets: capital equipment and disposable probes.
- Balloon Dilation Device Market – MedCore – This analysis considers only the balloon catheter components of BSD and excludes all other components of a BSD system.
- Drug-Eluting Stent Market – MedCore
- Bronchoscope Market – MedCore – Segmented into 3 main markets: rigid bronchoscopes, flexible bronchoscopes and ultrasound bronchoscopes.
- Bronchoscopic Hand Instrument Market – MedCore
- Tracheobronchial Stent Market – MedCore – Segmented into 2 main markets: metal tracheobronchial stents and silicone tracheobroncial stents
- Foreign Body Removal Market – MedCore – Segmented into 2 main markets: reusable and disposable devices.
RESEARCH SCOPE SUMMARY
Report Attribute | Details |
---|---|
Region | North America (United States) |
Base Year | 2022 |
Forecast | 2023-2029 |
Historical Data | 2019-2022 |
Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
Qualitative Coverage | COVID-19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, Disease Overviews. |
Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
WHY CHOOSE IDATA?
- Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.
- Global Coverage – iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.
- Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.
- Pricing – When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.
Table of Contents
TABLE of CONTENTS |
List of Figures |
List of Charts |
executive summary |
U.S. ENT Endoscopic and Bronchoscopic Device Market Overview |
Competitive Analysis |
Market Trends |
Market Developments |
Procedure Numbers |
Procedure Codes Investigated |
Markets Included |
Key Report Updates |
Version History |
research methodology |
Step 1: Project Initiation & Team Selection |
Step 2: Prepare Data Systems and Perform Secondary Research |
Step 3: Preparation for Interviews & Questionnaire Design |
Step 4: Performing Primary Research |
Step 5: Research Analysis: Establishing Baseline Estimates |
Step 6: Market Forecast and Analysis |
Step 7: Identify Strategic Opportunities |
Step 8: Final Review and Market Release |
Step 9: Customer Feedback and Market Monitoring |
impact of covid-19 on THE U.S. ENT Endoscopic and Bronchoscopic Device Market |
2.1 Introduction |
2.2 Analysis By Market Segment |
2.2.1 Worst Case Scenario |
2.2.2 Base Case Scenario |
2.2.3 Best Case Scenario |
Disease Overview |
3.1 Basic Anatomy |
3.1.1 Ears (Otology) |
3.1.2 Nose |
3.1.3 Throat |
3.1.4 Trachea |
3.1.5 Bronchi |
3.2 Diseases and Conditions |
3.2.1 Ears (Otology) |
3.2.2 Nose |
3.2.3 Throat |
3.2.4 Trachea |
3.2.5 Bronchi |
3.3 Patient Demographics |
3.3.1 Ears (Otology) |
3.3.2 Nose |
3.3.3 Throat |
3.3.4 Trachea |
3.3.5 Bronchi |
3.4 Procedures |
3.4.1 Ear |
3.4.1.1 Tympanoplasty / Mastoidectomy |
3.4.1.2 Myringotomy |
3.4.2 Nose |
3.4.2.1 Sinus |
3.4.2.2 Turbinate Reduction |
3.4.3 Throat |
3.4.3.1 Tonsillectomy |
3.4.3.2 Adenoidectomy |
3.4.3.3 Combined (T&A) |
3.4.4 Bronchoscopy procedures |
3.4.4.1 Bronchial Stenting and Dilation Procedures |
3.4.4.2 Pulmonary Biopsy Procedures |
3.4.4.3 Tumor Removal Procedures |
3.4.4.1 Foreign Body Removal Procedures |
Product Assessment |
4.1 Introduction |
4.2 Product Portfolios |
4.2.1 ENT Endoscopic Devices |
4.2.1.1 ENT Endoscopes |
4.2.1.1.1 Single-Use ENT Endoscopes |
4.2.1.1.2 Reusable Laryngoscope |
4.2.1.1.3 Reusable Rhinoscopes/Sinuscopes |
4.2.1.1.4 Reusable Otoscope |
4.2.1.2 Powered Instruments |
4.2.1.2.1 Capital Equipment |
4.2.1.2.2 Disposables |
4.2.1.3 ENT Hand Instruments |
4.2.1.3.1 Sinus |
4.2.1.3.2 Laryngeal |
4.2.1.3.3 Otology |
4.2.1.4 Surgical Energy Devices |
4.2.1.5 Balloon Sinus Dilation Devices |
4.2.1.6 Drug Eluting Stents |
4.2.2 Bronchoscopic Devices |
4.2.2.1 Bronchoscopes |
4.2.2.1.1 Rigid Bronchoscopes |
4.2.2.1.2 Flexible bronchoscopes |
4.2.2.1.3 Ultrasound Bronchoscopes |
4.2.2.1.4 Single-Use Bronchoscopes |
4.2.2.2 Bronchoscopic Hand Instruments |
4.2.2.3 Tracheobronchial Stent |
4.2.2.3.1 Metal Stent |
4.2.2.3.2 Silicone Stent |
4.2.2.4 Biopsy Devices |
4.2.2.4.1 Bronchial Forceps |
4.2.2.4.2 Transbronchial Needle Aspiration |
4.2.2.5 Foreign Body Removal |
4.3 Regulatory Issues and Recalls |
4.3.1 ENT Endoscopes |
4.3.1.1 Ambu |
4.3.1.2 Karl Storz |
4.3.1.3 Medtronic |
4.3.1.4 Olympus |
4.3.1.5 Pentax |
4.3.1.6 Teleflex Medical |
4.3.1.7 Verathon |
4.3.2 Powered Instruments |
4.3.2.1 Medtronic |
4.3.2.2 Stryker |
4.3.3 ENT Hand Instruments |
4.3.3.1 Olympus |
4.3.3.2 Richard Wolf |
4.3.3.3 Stryker |
4.3.4 Surgical Energy Devices |
4.3.4.1 Ethicon |
4.3.4.2 Medtronic |
4.3.5 Bronchoscopes |
4.3.5.1 Karl Storz |
4.3.5.2 Lymol Medical |
4.3.5.3 Olympus |
4.3.6 Tracheobronchial Stents |
4.3.6.1 Getinge |
4.3.6.2 Lymol Medical |
4.3.7 Biopsy Devices |
4.3.7.1 Cook Medical |
4.3.7.2 Olympus Medical |
4.3.7.3 Hobbs Medical |
4.3.8 Foreign Body Removal |
4.3.8.1 Hobbs Medical |
4.3.8.2 Olympus |
4.4 Clinical Trials |
4.4.1 ENT Endoscopic Devices |
4.4.1.1 ENT Endoscopes |
4.4.1.2 Surgical Energy Devices |
4.4.1.3 Balloon Sinus Dilation Devices |
4.4.2 Bronchoscopic devices |
4.4.2.1 Bronchoscopes |
4.4.2.2 Tracheobronchial Stents |
4.4.2.3 Biopsy Devices |
4.4.2.4 Foreign Body Removal |
U.S. ENT Endoscopic Device Market Overview |
5.1 Introduction |
5.2 Market Overview & Trend Analysis |
5.3 Drivers and Limiters |
5.3.1 Market Drivers |
5.3.2 Market Limiters |
5.4 Competitive Market Share Analysis |
5.5 Mergers and Acquisitions |
5.6 Company Profiles |
5.6.1 Acclarent |
5.6.2 Ambu |
5.6.3 Karl Storz |
5.6.4 Medtronic |
5.6.5 Olympus |
5.6.6 Pentax |
5.6.7 Smith & Nephew |
5.6.8 Stryker |
5.7 SWOT Analysis |
5.7.1 Acclarent |
5.7.2 Ambu |
5.7.3 Karl Storz |
5.7.4 Medtronic |
5.7.5 Olympus |
5.7.6 Pentax |
5.7.7 Smith & Nephew |
5.7.8 Stryker |
ENT Procedure Numbers |
6.1 Introduction |
6.2 Procedures |
6.2.1 Total ENT Procedures |
6.2.2 Total Otological Procedures |
6.2.2.1 Tympanoplasty / Mastoidectomy Procedures |
6.2.2.2 Myringotomy Procedures |
6.2.3 Total Nose Procedures |
6.2.3.1 Sinus Procedures |
6.2.3.2 Turbinate Reduction Procedures |
6.2.3.3 Septoplasty Procedures |
6.2.4 Total Throat Procedures |
6.2.4.1 Tonsillectomy Procedures |
6.2.4.2 Adenoidectomy Procedures |
6.2.4.3 Combined Procedures |
ENT Endoscope Market |
7.1 Introduction |
7.2 Market Overview |
7.3 Market Analysis and Forecast |
7.3.1 Single-Use ENT Endoscope Market |
7.3.1.1 Single-Use Rhinolaryngoscope Market |
7.3.1.1.1 Hospital Single-Use Rhinolaryngoscope Market |
7.3.1.1.2 Non-Hospital Single-Use Rhinolaryngoscope Market |
7.3.1.2 Single-Use Intubation Endoscope Market |
7.3.1.2.1 Single-Use Intubation Endoscope Market by Device Type |
7.3.1.2.2 Single-Use Intubation Endoscope Market by Care Setting |
7.3.2 Reusable Laryngoscope Market |
7.3.2.1 Rigid Laryngoscope Market |
7.3.2.1.1 Hospital Rigid Laryngoscope Market |
7.3.2.1.2 Non-Hospital Rigid Laryngoscope Market |
7.3.2.2 Flexible Laryngoscope Market |
7.3.2.2.1 Flexible Laryngoscope Market by Device Type |
7.3.2.2.2 Flexible Laryngoscope Market by Care Setting |
7.3.2.3 Direct Laryngoscope Market |
7.3.2.3.1 Direct Laryngoscope Blade Market by Device Type |
7.3.2.3.2 Direct Laryngoscope Blade Market by Care Setting |
7.3.2.3.3 Direct Laryngoscope Handle Market by Care Setting |
7.3.3 Reusable Rhinoscope/Sinuscope Market |
7.3.4 Reusable Otoscope Market |
7.4 Drivers and Limiters |
7.4.1 Market Drivers |
7.4.2 Market Limiters |
7.5 Competitive Market Share Analysis |
ENT Powered Instrument Market |
8.1 Introduction |
8.2 Market Overview |
8.3 Market Analysis and Forecast |
8.3.1 ENT Powered Instrument Capital Equipment Market |
8.3.1.1 ENT Power Shaver Market |
8.3.1.2 ENT Power Drill Market |
8.3.2 ENT Powered Instrument Disposables Market |
8.3.2.1 ENT Shaver Blade Market |
8.3.2.2 Navigation ENT Shaver Blade Market |
8.3.2.3 Regular ENT Shaver Blade Market |
8.3.2.4 ENT Drill Bur Market |
8.4 Drivers and Limiters |
8.4.1 Market Drivers |
8.4.2 Market Limiters |
8.5 Competitive Market Share Analysis |
ENT Hand Instrument Market |
9.1 Introduction |
9.2 Market Overview |
9.3 Market Analysis and Forecast |
9.3.1 ENT Hand Instrument Market |
9.3.2 Sinus Hand Instrument Market |
9.3.3 Laryngeal Hand Instrument Market |
9.3.4 Otology Hand Instrument Market |
9.4 Drivers and Limiters |
9.4.1 Market Drivers |
9.4.2 Market Limiters |
9.5 Competitive Market Share Analysis |
ENT Surgical Energy Device Market |
10.1 Introduction |
10.2 Market Overview |
10.3 Market Analysis and Forecast |
10.3.1 Capital Equipment Market |
10.3.2 RF & Ultrasonic Probe Market |
10.4 Drivers and Limiters |
10.4.1 Market Drivers |
10.4.2 Market Limiters |
10.5 Competitive Market Share Analysis |
Balloon Dilation Device Market |
11.1 Introduction |
11.2 Market Analysis and Forecast |
11.3 Drivers and Limiters |
11.3.1 Market Drivers |
11.3.2 Market Limiters |
11.4 Competitive Market Share Analysis |
Drug-Eluting Stent Market |
12.1 Introduction |
12.2 Market Analysis and Forecast |
12.3 Drivers and Limiters |
12.3.1 Market Drivers |
12.3.2 Market Limiters |
12.4 Competitive Market Share Analysis |
U.S. Bronchoscopic Device Market Overview |
13.1 Introduction |
13.2 Market Overview & Trend Analysis |
13.3 Drivers and Limiters |
13.3.1 Market Drivers |
13.3.2 Market Limiters |
13.4 Competitive Market Share Analysis |
13.5 Mergers and Acquisitions |
13.6 Company Profiles |
13.6.1 Ambu |
13.6.2 Boston Scientific |
13.6.3 Getinge |
13.6.4 Karl Storz |
13.6.5 Olympus |
13.6.6 Pentax |
13.7 SWOT Analysis |
13.7.1 Ambu |
13.7.2 Boston Scientific |
13.7.3 Getinge |
13.7.4 Karl Storz |
13.7.5 Olympus |
13.7.6 Pentax |
Bronchoscopy Procedure Numbers |
14.1 Procedures |
14.1.1 Total Bronchoscopic Procedures |
14.1.2 Tracheobronchial Stenting and Dilation Procedures |
14.1.3 Pulmonary Sampling Procedures |
14.1.3.1 Pulmonary Biopsy Procedures |
14.1.4 Tumor Removal Procedures |
14.1.5 Foreign Body Removal Procedures |
Bronchoscope Market |
15.1 Introduction |
15.2 Market Overview |
15.3 Market Analysis and Forecast |
15.3.1 Total Rigid Bronchoscope Market |
15.3.1.1 Rigid Bronchoscope Market by Type |
15.3.1.1.1 Rigid Bronchoscope Device Market |
15.3.1.1.2 Rigid Bronchoscopic Tube Market |
15.3.1.2 Rigid Bronchoscope Market by Care Setting |
15.3.1.3 Hospital Rigid Bronchoscope Market |
15.3.1.4 Non-Hospital Rigid Bronchoscope Market |
15.3.2 Total Flexible Bronchoscope Market |
15.3.2.1 Flexible Bronchoscope Market by Type |
15.3.2.2 Fiber Flexible Bronchoscope Market |
15.3.2.3 Video Flexible Bronchoscope Market |
15.3.2.4 Flexible Bronchoscope Market by Care Setting |
15.3.2.5 Hospital Flexible Bronchoscope Market |
15.3.2.6 Non-Hospital Flexible Bronchoscope Market |
15.3.3 Ultrasound Bronchoscope Market |
15.3.3.1 Hospital Ultrasound Bronchoscope Market |
15.3.3.2 Non-Hospital Ultrasound Bronchoscope Market |
15.3.4 Single-Use Bronchoscope Market |
15.3.4.1 Hospital Single-Use Bronchoscope Market |
15.3.4.2 Non-Hospital Single-Use Bronchoscope Market |
15.4 Drivers and Limiters |
15.4.1 Market Drivers |
15.4.2 Market Limiters |
15.5 Competitive Market Share Analysis |
Bronchoscopic Hand Instrument Market |
16.1 Introduction |
16.2 Market Analysis and Forecast |
16.3 Drivers and Limiters |
16.3.1 Market Drivers |
16.3.2 Market Limiters |
16.4 Competitive Market Share Analysis |
Tracheobronchial Stent Market |
17.1 Introduction |
17.2 Market Overview |
17.3 Market Analysis and Forecast |
17.3.1 Tracheobronchial Stent Market |
17.3.2 Metal Tracheobronchial Stent Market |
17.3.3 Silicone Tracheobronchial Stent Market |
17.4 Drivers and Limiters |
17.4.1 Market Drivers |
17.4.2 Market Limiters |
17.5 Competitive Market Share Analysis |
Bronchoscopic Biopsy Device Market |
18.1 Introduction |
18.2 Market Overview |
18.3 Market Analysis and Forecast |
18.3.1 Total Bronchial Forceps Market |
18.3.1.1 Disposable Bronchial Forceps Market |
18.3.1.2 Reusable Bronchial Forceps Market |
18.3.2 Total Transbronchial Aspiration Needle Market |
18.3.2.1 Conventional TBNA Market |
18.3.2.2 EBUS-TBNA Market |
18.4 Drivers and Limiters |
18.4.1 Market Drivers |
18.4.2 Market Limiters |
18.5 Competitive Market Share Analysis |
Foreign Body Removal Device Market |
19.1 Introduction |
19.2 Market Overview |
19.3 Market Analysis and Forecast |
19.3.1 Foreign Body Removal Device Market |
19.3.2 Disposable Foreign Body Removal Device Market |
19.3.3 Reusable Foreign Body Removal Device Market |
19.4 Drivers and Limiters |
19.4.1 Market Drivers |
19.4.2 Market Limiters |
19.5 Competitive Market Share Analysis |
Abbreviations |
Companies Included:
Acclarent | ERBE | MedRx |
Advanced Monitors Corporation | Ethicon | Medtronic |
Aesculap | Fujinon | Merit Medical |
Ambu | Getinge | Micromed Medizintechnik |
American Diagnostic Corporation | GlobalMed | Millennium Surgical |
Anthony Products | Grace Medical | Nouvag AG |
ASSI | Hayden Medical | Olympus |
ATMOS MedizinTechnik | Heine | OmniGuide |
Bausch & Lomb | Hobbs Medical | Otometrics |
BD | Hood Laboratories | Pentax |
Bien-Air | Instrumentarium | Richard Wolf |
BOMImed | Integra LifeSciences | Riester |
Boston Medical Products | Intersect ENT | Sklar Surgical Instruments |
Boston Scientific | IntuBrite | Smith & Nephew |
Bovie Medical | Inventis | Stryker |
BR Surgical | Invotec | Sutter |
Brasseler | JEDMED | Symmetry Surgical |
Clarus Medical | Karl Storz | Teleflex |
Cogentix Medical | KaWe | TeleMed Systems |
ConMed | KLS Martin | Thoracent |
Cook Medical | LYMOL Medical | US Endoscopy |
DePuy Synthes | Machida | Verathon |
Ecleris | Medi-Globe | Welch Allyn |
List of Charts
Chart 1‑1: ENT Endoscopic and Bronchoscopic Device Market by Segment, U.S., 2022 – 2029 |
Chart 1‑2: ENT Endoscopic and Bronchoscopic Device Market Overview, U.S., 2022 & 2029 |
Chart 2‑1: Multi-Scenario ENT Endoscopic and Bronchoscopic Device Market Forecast, U.S., 2019 – 2029 (US$M) |
Chart 5‑1: ENT Endoscopic Device Market by Segment, U.S., 2019 – 2029 |
Chart 5‑2: Leading Competitors, ENT Endoscopic Device Market, U.S., 2022 |
Chart 6‑1: Total ENT Procedures by Anatomy, U.S., 2019 – 2029 |
Chart 7‑1: ENT Endoscope Market by Segment, U.S., 2019 – 2029 |
Chart 7‑2: Leading Competitors, ENT Endoscope Market, U.S., 2022 |
Chart 8‑1: ENT Powered Instrument Market by Segment, U.S., 2019 – 2029 |
Chart 8‑2: Leading Competitors, ENT Powered Instrument Market, U.S., 2022 |
Chart 9‑1: ENT Hand Instrument Market by Segment, U.S., 2019 – 2029 |
Chart 9‑2: Leading Competitors, ENT Hand Instrument Market, U.S., 2022 |
Chart 10‑1: ENT Surgical Energy Device Market by Type, U.S., 2019 – 2029 |
Chart 10‑2: Leading Competitors, ENT Surgical Energy Device Market, U.S., 2022 |
Chart 11‑1: Balloon Dilation Device Market, U.S., 2019 – 2029 |
Chart 11‑2: Leading Competitors, Balloon Dilation Device Market, U.S., 2022 |
Chart 12‑1: Drug-Eluting Stent Market, U.S., 2019 – 2029 |
Chart 13‑1: Bronchoscopic Device Market by Segment, U.S., 2019 – 2029 |
Chart 13‑2: Leading Competitors, Bronchoscopic Device Market, U.S., 2022 |
Chart 14‑1: Bronchoscopic Procedures by Type, U.S., 2019 – 2029 |
Chart 15‑1: Bronchoscope Market by Segment, U.S., 2019 – 2029 |
Chart 15‑2: Leading Competitors, Bronchoscope Market, U.S., 2022 |
Chart 16‑1: Bronchoscopic Hand Instrument Market, U.S., 2019 – 2029 |
Chart 16‑2: Leading Competitors, Bronchoscopic Hand Instrument Market, U.S., 2022 |
Chart 17‑1: Tracheobronchial Stent Market by Segment, U.S., 2019 – 2029 |
Chart 17‑2: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022 |
Chart 18‑1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 – 2029 |
Chart 18‑2: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022 |
Chart 19‑1: Foreign Body Removal Device Market by Segment, U.S., 2019 – 2029 |
Chart 19‑2: Leading Competitors, Foreign Body Removal Device Market, U.S., 2022 |
List of Figures
Figure 1‑1: ENT Endoscopic and Bronchoscopic Device Market Share Ranking by Segment, U.S., 2022 (1 of 2) |
Figure 1‑2: ENT Endoscopic and Bronchoscopic Device Market Share Ranking by Segment, U.S., 2022 (2 of 2) |
Figure 1‑3: Companies Researched in This Report |
Figure 1‑4: Factors Impacting the ENT Endoscopic and Bronchoscopic Device Market by Segment, U.S. (1 of 2) |
Figure 1‑5: Factors Impacting the ENT Endoscopic and Bronchoscopic Device Market by Segment, U.S. (2 of 2) |
Figure 1‑6: Recent Events in the ENT Endoscopic and Bronchoscopic Device Market, U.S., 2019 – 2022 |
Figure 1‑7: ENT Endoscopic and Bronchoscopic Device Procedures Covered |
Figure 1‑8: Procedure Codes Investigated |
Figure 1‑9: Endoscopic and Bronchoscopic Device Markets Covered (1 of 4) |
Figure 1‑10: Endoscopic and Bronchoscopic Device Markets Covered (2 of 4) |
Figure 1‑11: Endoscopic and Bronchoscopic Device Markets Covered (3 of 4) |
Figure 1‑12: Endoscopic and Bronchoscopic Device Markets Covered (4 of 4) |
Figure 1‑13: Key Report Updates |
Figure 1‑14: Version History |
Figure 2‑1: ENT Endoscopic and Bronchoscopic Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) |
Figure 2‑2: ENT Endoscopic and Bronchoscopic Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) |
Figure 2‑3: ENT Endoscopic and Bronchoscopic Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) |
Figure 4‑1: Single-Use Endoscope Devices by Company |
Figure 4‑2: Rigid Laryngoscope Devices by Company (1 of 2) |
Figure 4‑3: Rigid Laryngoscope Devices by Company (2 of 2) |
Figure 4‑4: Flexible Laryngoscope Devices by Company |
Figure 4‑5: Direct Laryngoscope Devices by Company |
Figure 4‑6: Reusable Rhinoscopes/Sinuscopes by company |
Figure 4‑7: Reusable Otoscopes by Company |
Figure 4‑8: Powered Instruments, Capital Equipment Devices by Company |
Figure 4‑9: Powered Instruments, Disposables Devices by Company |
Figure 4‑10: Hand Instrument Devices by Company |
Figure 4‑11: Surgical Energy Devices by Company |
Figure 4‑12: Balloon Sinus Dilation Devices by Company |
Figure 4‑13: Drug Eluting Stent Devices by Company |
Figure 4‑14: Rigid Bronchoscope Devices by Company |
Figure 4‑15: Flexible Bronchoscope Devices by Company |
Figure 4‑16: Ultrasound Bronchoscope Devices by Company |
Figure 4‑17: Single Use Bronchoscope Devices by Company |
Figure 4‑18: Bronchoscopic Hand Instrument Devices by Company |
Figure 4‑19: Metal Stent Devices by Company |
Figure 4‑20: Silicone Stent Devices by Company |
Figure 4‑21: Bronchial Biopsy Forceps Devices by Company |
Figure 4‑22: Transbronchial Needle Aspiration Devices by Company |
Figure 4‑23: Foreign Body Removal Devices by Company |
Figure 4‑24: Class 2 Device Recall Ambu VivaSight 2 DLT |
Figure 4‑25: Class 1 Device Recall King Vision Video Adapter Size 1/2 |
Figure 4‑26: Class 2 Device Recall Nasopharyngolaryngoscope |
Figure 4‑27: Class 2 Device Recall KARL STORZ |
Figure 4‑28: Class 2 Device Recall KARL STORZ |
Figure 4‑29: Class 2 Device Recall Video Laryngoscope |
Figure 4‑30: Class 2 Device Recall McGrath |
Figure 4‑31: Class 2 Device Recall Olympus ENDOEYE HD II Video Telescopes |
Figure 4‑32: Class 2 Device Recall Pentax Rigid Laryngostroboscopes |
Figure 4‑33: Class 2 Device Recall Rusch Greenlite Single Use Metal Laryngoscope Blade for Fiber Optic System |
Figure 4‑34: Class 2 Device Recall Rusch |
Figure 4‑35: Class 2 Device Recall RUSCH POLARIS Laryngoscope |
Figure 4‑36: Class 1 Device Recall GlideScope Core OneTouch Smart Cable |
Figure 4‑37: Class 2 Device Recall GlideScope Video Laryngoscope |
Figure 4‑38: Class 2 Device Recall Medtronic |
Figure 4‑39: Class 2 Device Recall Entellus Medical Shaver System |
Figure 4‑40: Class 2 Device Recall Stryker Instruments S2 Mini Foot Pedal |
Figure 4‑41: Class 2 Device Recall Stryker Sustainability Solutions (SSS) |
Figure 4‑42: Class 2 Device Recall Olympus |
Figure 4‑43: Class 2 Device Recall Bronchoscope Tubes |
Figure 4‑44: Class 2 Device Recall Reprocessed Coronary Sinus Diagnostic EP Catheter |
Figure 4‑45: Class 2 Device Recall Stryker PROFESS |
Figure 4‑46: Class 2 Device Recall Ethicon |
Figure 4‑47: Class 2 Device Recall Ethicon |
Figure 4‑48: Class 2 Device Recall Covidien Emprint Ablation Catheter with Thermosphere Technology Bronchoscopic Ablation |
Figure 4‑49: Class 2 Device Recall Covidien Sonicision Battery Charger |
Figure 4‑50: Class 2 Device Recall Covidien |
Figure 4‑51: Class 2 Device Recall Flexible Bronchoscope |
Figure 4‑52: Class 2 Device Recall Intubation Fiberscope |
Figure 4‑53: Class 2 Device Recall LYMOL Medical Elite X Class Rigid Bronchoscope System |
Figure 4‑54: Class 2 Device Recall EVIS EXERA III |
Figure 4‑55: Class 2 Device Recall Olympus |
Figure 4‑56: Class 2 Device Recall Bronchofiberscopes |
Figure 4‑57: Class 2 Device Recall EVIS EXERA Bronchovideoscopes |
Figure 4‑58: Class 2 Device Recall Olympus BFQ180 Bronchoscope |
Figure 4‑59: Class 2 Device Recall Olympus MAJ209 Single Use Suction Valve (MAJ209) |
Figure 4‑60: Class 1 Device Recall Atrium |
Figure 4‑61: WARNING LETTER Lymol Medical Corporation |
Figure 4‑62: Class 2 Device Recall Captura Serrated Forceps with Spike |
Figure 4‑63: Class 2 Device Recall ASPIRATION NEEDLE VIZISHOT |
Figure 4‑64: Class 2 Device Recall ASPIRATION NEEDLE |
Figure 4‑65: Class 2 Device Recall Hobbs |
Figure 4‑66: Class 2 Device Recall Hobbs Bronchial Cytology Brushes |
Figure 4‑67: Class 2 Device Recall Hobbs |
Figure 4‑68: Class 2 Device Recall Olympus |
Figure 4‑69: Study of Cost-effectiveness of the Airway Management in Thoracic Surgery |
Figure 4‑70: Direct Versus Video Laryngoscope Trial (device) |
Figure 4‑71: C-MAC Video Stylet vs. Video Endoscope |
Figure 4‑72: Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults |
Figure 4‑73: GlideScope Videolaryngoscopy in Patients with Reduced Mouth Opening |
Figure 4‑74: VivaSight-SL Versus Videolaryngoscopy in Expected Difficult Airway (VivaOP) |
Figure 4‑75: Comparison of Videolaryngoscopy and Direct Laryngoscopy in Pediatric Airway Management |
Figure 4‑76: Conventional Intubation Versus VivaSight™-SL (VivaITN) |
Figure 4‑77: Comparison of Endotracheal Intubation Using Flexible Fiberoptic Bronchoscopy Versus Flexible Intubation Video Endoscope (FIVE) in Obese Patients Undergoing Elective Surgeries Under General Anesthesia: A Randomized Controlled Trial |
Figure 4‑78: A Study of the ENSEAL® X1 Curved Jaw Tissue Sealer and Generator G11 in Thoracic, Urologic, and Ear, Nose, and Throat (ENT) Procedures |
Figure 4‑79: A Prospective, Multi-Center Evaluation of the ENSEAL X1 Large Jaw Tissue Sealer |
Figure 4‑80: Balloon Sinuplasty Efficiency in Maxillary Rhinosinusitis. |
Figure 4‑81: A Clinical Evaluation of PROPEL® Contour Sinus Implant (EXPAND) |
Figure 4‑82: Treatment of Chronic Frontal Sinusitis by a Simple Technique Using Dilation Balloons (SIBA) |
Figure 4‑83: Video-Laryngoscope Alone or With Bronchoscope for Predicted Difficult Intubation (COMBO) |
Figure 4‑84: Pilot Study to Evaluate the Role of EBUS in the Diagnosis of Acute PE in Critically Ill Patients (VEBUS) |
Figure 4‑85: Evaluation of a Disposable Flexible Bronchoscope, aScope IV (EVAL) |
Figure 4‑86: TRAcheostomy with Single Use Bronchoscopes vs. Conventional Bronchoscopes |
Figure 4‑87: Reusable Flexible Bronchoscopes Versus Single Use Bronchoscopes: a Satisfaction Survey |
Figure 4‑88: Prospective Non-interventional Evaluation of Intubation and Intensive Care Use of the New aScope™ 4 Broncho and aView |
Figure 4‑89: Airway Stents for Excessive Dynamic Airway Collapse |
Figure 4‑90: Evaluating the Clinical Effectiveness of a Patient-specific Silicone Stent |
Figure 4‑91: Biodegradable Airway Stent Post Lung Transplant |
Figure 4‑92: Central Malignant Airway Obstructions: Medical Treatment Alone Versus Endoscopic and Medical Treatment (EVERMORE) |
Figure 4‑93: Stent Versus Balloon Dilatation in Patients with Tracheal Benign Stenosis (STROBE) |
Figure 4‑94: Evaluating the Clinical Effectiveness of 3D Printing for a Patient-specific Silicone Stent Airway Implant |
Figure 4‑95: Evaluation of the Synergistic Impact of Needle and Forceps Biopsy with Electromagnetic Navigation Bronchoscopy |
Figure 4‑96: Needle-Based Confocal Laser Endomicroscopy with Fluorescein and Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for the Diagnosis of Lung Cancer in Patients With Peripheral Pulmonary Nodules |
Figure 4‑97: Thin and Ultrathin Bronchoscopy with Transbronchial Needle Aspiration and Radial Probe Endobronchial Ultrasound for Peripheral Pulmonary Lesions |
Figure 4‑98: EBUS TBNA After PET/CT in Diagnosing Patients with Stage I-IIA Non-small Cell Lung Cancer Evaluated for Stereotactic Body Radiation Therapy |
Figure 4‑99: Effect of Needle Size in Diagnostic Yield of EBUS-TBNA in Sarcoidosis and Lymphoma |
Figure 4‑100: Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle |
Figure 4‑101: Foreign Body Ingestion During COVID-19 Lockdown |
Figure 4‑102: Comparison of Patients with and Without Foreign Body Aspiration After Bronchoscopy. |
Figure 4‑103: High Flow Nasal Cannula in Comparison to Apneic Oxygenation During Foreign Body Removal by Rigid Bronchoscope |
Figure 5‑1: ENT Endoscopic Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 5‑2: Leading Competitors, ENT Endoscopic Device Market, U.S., 2022 |
Figure 5‑3: SWOT Analysis, Acclarent |
Figure 5‑4: SWOT Analysis, Ambu |
Figure 5‑5: SWOT Analysis, Karl Storz |
Figure 5‑6: SWOT Analysis, Medtronic |
Figure 5‑7: SWOT Analysis, Olympus |
Figure 5‑8: SWOT Analysis, Pentax |
Figure 5‑9: SWOT Analysis, Smith & Nephew |
Figure 5‑10: SWOT Analysis, Stryker |
Figure 6‑1: Procedure Codes Investigated, U.S., 2021 |
Figure 6‑2: Total ENT Procedures by Anatomy, U.S., 2019 – 2029 |
Figure 6‑3: Otological Procedures by Type, U.S., 2019 – 2029 |
Figure 6‑4: Tympanoplasty / Mastoidectomy Procedures, U.S., 2019 – 2029 |
Figure 6‑5: Myringotomy Procedures, U.S., 2019 – 2029 |
Figure 6‑6: Nose Procedures by Type, U.S., 2019 – 2029 |
Figure 6‑7: Sinus Procedures, U.S., 2019 – 2029 |
Figure 6‑8: Turbinate Reduction Procedures, U.S., 2019 – 2029 |
Figure 6‑9: Septoplasty Procedures, U.S., 2019 – 2029 |
Figure 6‑10: Throat Procedures by Type, U.S., 2019 – 2029 |
Figure 6‑11: Tonsillectomy Procedures, U.S., 2019 – 2029 |
Figure 6‑12: Adenoidectomy Procedures, U.S., 2019 – 2029 |
Figure 6‑13: Combined Procedures, U.S., 2019 – 2029 |
Figure 7‑1: ENT Endoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 7‑2: Single-Use ENT Endoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 7‑3: Total Single-Use ENT Endoscope Market, U.S., 2019 – 2029 |
Figure 7‑4: Single-Use Rhinolaryngoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 7‑5: Total Single-Use Rhinolaryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑6: Hospital Single-Use Rhinolaryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑7: Non-Hospital Single-Use Rhinolaryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑8: Single-Use Intubation Endoscope Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 7‑9: Total Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
Figure 7‑10: Flexible Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
Figure 7‑11: Single-Use Fiberoptic Blade Market, U.S., 2019 – 2029 |
Figure 7‑12: Single-Use Video Blade Market, U.S., 2019 – 2029 |
Figure 7‑13: Single-Use Intubation Endoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 7‑14: Hospital Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
Figure 7‑15: Non-Hospital Single-Use Intubation Endoscope Market, U.S., 2019 – 2029 |
Figure 7‑16: Reusable Laryngoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 7‑17: Total Reusable Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑18: Rigid Laryngoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 7‑19: Total Rigid Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑20: Hospital Rigid Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑21: Non-Hospital Rigid Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑22: Flexible Laryngoscope Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 7‑23: Total Flexible Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑24: Video Flexible Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑25: Fiber Optic Flexible Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑26: Flexible Laryngoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 7‑27: Hospital Flexible Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑28: Non-Hospital Flexible Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑29: Direct Laryngoscope Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 7‑30: Total Direct Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑31: Direct Laryngoscope Blade Market by Device Type, U.S., 2019 – 2029 (US$M) |
Figure 7‑32: Total Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑33: Direct Video Blade Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑34: Direct Non-Video Blade Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑35: Direct Laryngoscope Blade Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 7‑36: Total Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑37: Hospital Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑38: Non-Hospital Direct Blade Laryngoscope Market, U.S., 2019 – 2029 |
Figure 7‑39: Direct Laryngoscope Handle Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 7‑40: Hospital Direct Laryngoscope Handle Market, U.S., 2019 – 2029 |
Figure 7‑41: Non-Hospital Direct Laryngoscope Handle Market, U.S., 2019 – 2029 |
Figure 7‑42: Reusable Rhinoscope/Sinuscope Market, U.S., 2019 – 2029 |
Figure 7‑43: Reusable Otoscope Market, U.S., 2019 – 2029 |
Figure 7‑44: Leading Competitors, ENT Endoscope Market, U.S., 2022 |
Figure 8‑1: ENT Powered Instrument Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 8‑2: ENT Powered Instrument Capital Equipment Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 8‑3: Total ENT Powered Instrument Capital Equipment Market, U.S., 2019 – 2029 |
Figure 8‑4: ENT Power Shaver Market, U.S., 2019 – 2029 |
Figure 8‑5: ENT Power Drill Market, U.S., 2019 – 2029 |
Figure 8‑6: ENT Powered Instrument Disposables Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 8‑7: Total ENT Powered Instrument Disposables Market, U.S., 2019 – 2029 |
Figure 8‑8: ENT Shaver Blade Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 8‑9: Total ENT Shaver Blade Market, U.S., 2019 – 2029 |
Figure 8‑10: Navigation ENT Shaver Blade Market, U.S., 2019 – 2029 |
Figure 8‑11: Regular ENT Shaver Blade Market, U.S., 2019 – 2029 |
Figure 8‑12: ENT Drill Bur Market, U.S., 2019 – 2029 |
Figure 8‑13: Leading Competitors, ENT Powered Instrument Market, U.S., 2022 |
Figure 9‑1: ENT Hand Instrument Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 9‑2: ENT Hand Instrument Market, U.S., 2019 – 2029 |
Figure 9‑3: Sinus Hand Instrument Market, U.S., 2019 – 2029 |
Figure 9‑4: Laryngeal Hand Instrument Market, U.S., 2019 – 2029 |
Figure 9‑5: Otology Hand Instrument Market, U.S., 2019 – 2029 (US$M) |
Figure 9‑6: Leading Competitors, ENT Hand Instrument Market, U.S., 2022 |
Figure 10‑1: ENT Surgical Energy Device Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 10‑2: Capital Equipment Market, U.S., 2019 – 2029 |
Figure 10‑3: RF & Ultrasonic Probe Market, U.S., 2019 – 2029 |
Figure 10‑4: Leading Competitors, ENT Surgical Energy Device Market, U.S., 2022 |
Figure 11‑1: Balloon Dilation Device Market, U.S., 2019 – 2029 |
Figure 11‑2: Leading Competitors, Balloon Dilation Device Market, U.S., 2022 |
Figure 12‑1: Drug-Eluting Stent Market, U.S., 2019 – 2029 |
Figure 12‑2: Leading Competitors, Drug-Eluting Stent Market, U.S., 2022 |
Figure 13‑1: Bronchoscopic Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 13‑2: Leading Competitors, Bronchoscopic Device Market, U.S., 2022 |
Figure 13‑3: SWOT Analysis, Ambu |
Figure 13‑4: SWOT Analysis, Boston Scientific |
Figure 13‑5: SWOT Analysis, Getinge |
Figure 13‑6: SWOT Analysis, Karl Storz |
Figure 13‑7: SWOT Analysis, Olympus |
Figure 13‑8: SWOT Analysis, Pentax |
Figure 14‑1: Bronchoscopic Procedures by Type, U.S., 2019 – 2029 |
Figure 14‑2: Tracheobronchial Stenting and Dilation Procedures by Type, U.S., 2019 – 2029 |
Figure 14‑3: Pulmonary Sampling Procedures by Type, U.S., 2019 – 2029 |
Figure 14‑4: Pulmonary Biopsy Procedures by Type, U.S., 2019 – 2029 |
Figure 14‑5: Tumor Removal Procedures, U.S., 2019 – 2029 |
Figure 14‑6: Foreign Body Removal Procedures, U.S., 2019 – 2029 |
Figure 15‑1: Bronchoscope Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 15‑2: Rigid Bronchoscope Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 15‑3: Rigid Bronchoscope Device Market, U.S., 2019 – 2029 |
Figure 15‑4: Rigid Bronchoscopic Tube Market, U.S., 2019 – 2029 |
Figure 15‑5: Rigid Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 15‑6: Hospital Rigid Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑7: Non-Hospital Rigid Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑8: Flexible Bronchoscope Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 15‑9: Total Flexible Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑10: Fiber Flexible Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑11: Video Flexible Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑12: Flexible Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 15‑13: Hospital Flexible Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑14: Non-Hospital Flexible Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑15: Ultrasound Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 15‑16: Hospital Ultrasound Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑17: Non-Hospital Ultrasound Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑18: Ultrasound Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑19: Single-Use Bronchoscope Market by Care Setting, U.S., 2019 – 2029 (US$M) |
Figure 15‑20: Hospital Single-Use Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑21: Non-Hospital Single-Use Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑22: Single-Use Bronchoscope Market, U.S., 2019 – 2029 |
Figure 15‑23: Leading Competitors, Bronchoscope Market, U.S., 2022 |
Figure 16‑1: Bronchoscopic Hand Instrument Market, U.S., 2019 – 2029 |
Figure 16‑2: Leading Competitors, Bronchoscopic Hand Instrument Market, U.S., 2022 |
Figure 17‑1: Tracheobronchial Stent Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 17‑2: Tracheobronchial Stent Market, U.S., 2019 – 2029 |
Figure 17‑3: Metal Tracheobronchial Stent Market, U.S., 2019 – 2029 |
Figure 17‑4: Silicone Tracheobronchial Stent Market, U.S., 2019 – 2029 |
Figure 17‑5: Leading Competitors, Tracheobronchial Stent Market, U.S., 2022 |
Figure 18‑1: Bronchoscopic Biopsy Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 18‑2: Bronchial Forceps Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 18‑3: Total Bronchial Forceps Market, U.S., 2019 – 2029 |
Figure 18‑4: Disposable Bronchial Forceps Market, U.S., 2019 – 2029 |
Figure 18‑5: Reusable Bronchial Forceps Market, U.S., 2019 – 2029 |
Figure 18‑6: Transbronchial Aspiration Needle Market by Type, U.S., 2019 – 2029 (US$M) |
Figure 18‑7: Total Transbronchial Aspiration Needle Market, U.S., 2019 – 2029 |
Figure 18‑8: Conventional TBNA Market, U.S., 2019 – 2029 |
Figure 18‑9: EBUS-TBNA Market, U.S., 2019 – 2029 |
Figure 18‑10: Leading Competitors, Bronchoscopic Biopsy Device Market, U.S., 2022 |
Figure 19‑1: Foreign Body Removal Device Market by Segment, U.S., 2019 – 2029 (US$M) |
Figure 19‑2: Foreign Body Removal Device Market, U.S., 2019 – 2029 |
Figure 19‑3: Disposable Foreign Body Removal Device Market, U.S., 2019 – 2029 |
Figure 19‑4: Reusable Foreign Body Removal Device Market, U.S., 2019 – 2029 |
Figure 19‑5: Leading Competitors, Foreign Body Removal Device Market, U.S., 2022 |
iData’s 9-Step Research Methodology
Our reports follow an in-depth 9-step methodology which focuses on the following research systems:- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.
Explore Options
Report Summary | FREE |
ENT & Bronchoscopy Devices Market Size, Share, & COVID-19 Impact Analysis | United States | 2023-2029 | MedSuite | Includes: ENT Endoscopes, ENT Powered Instruments, and 9 more
$7,995 – $9,995
- 2023
- 10 Years
- United States
- 12/15/2022
- 399
- MedSuite



